Speaker Profile
Ph.D., CEO & Co-Founder, 10x Genomics
Biography
Serge Saxonov is the co-founder and CEO of 10x Genomics, a leader in singlecell and spatial biology. 10xs mission is to accelerate the mastery ofbiology to advance human health. Under Serges leadership, 10x hasdelivered groundbreaking products that have transformed how researchersexplore biology. These tools and technologies have been cited in more than10,000 high-impact publications and have enabled discoveries across nearlyevery area of life sciences.As a scientist, inventor and entrepreneur, Serge guided 10x from anearly-stage startup through one of the fastest revenue ramps in theindustrys history to its public debut on Nasdaq (TXG), and has since ledthe companys continued growth and innovation. Before 10x, he was part ofthe founding team at 23andme, where he pioneered the companys coretechnology and product concepts, and later served as Vice President ofApplications at QuantaLife, which was acquired by Bio-Rad.Serges leadership and entrepreneurship have been recognized by GoldmanSachs, which named him one of its 100 Most Intriguing Entrepreneurs in2016, and by the San Francisco Business Times, which honored him as one ofthe Bay Areas Most Admired CEOs in 2021. He earned his A.B. in AppliedMathematics from Harvard College and his Ph.D. in Biomedical Informaticsfrom Stanford University.
Session Abstract – PMWC 2027 Silicon Valley
The PMWC 2026 AI Company Showcase will provide a 15-30 minute time slot for selected AI companies to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from companies building technologies that expedite the pre-clinical and clinical drug discovery and development process, accelerate patient diagnosis and treatment, or develop scalable systems framework to make AI and deep/machine learning a reality.
